Stuart Tross - Amgen Senior Vice President - Human Resources
AMGN Stock | MXN 4,450 6.50 0.15% |
President
Dr. Stuart A. Tross is the Senior Vice President Human Resources of Amgen Inc since 2013.
Age | 48 |
Tenure | 11 years |
Phone | 805 447 1000 |
Web | https://www.amgen.com |
Stuart Tross Latest Insider Activity
Tracking and analyzing the buying and selling activities of Stuart Tross against Amgen stock is an integral part of due diligence when investing in Amgen. Stuart Tross insider activity provides valuable insight into whether Amgen is net buyers or sellers over its current business cycle. Note, Amgen insiders must abide by specific rules, including filing SEC forms every time they buy or sell Amgen'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Stuart Tross over three months ago Acquisition by Stuart Tross of 100000 shares of MannKind Corp subject to Rule 16b-3 | ||
Stuart Tross over six months ago Acquisition by Stuart Tross of 90000 shares of MannKind Corp subject to Rule 16b-3 | ||
Stuart Tross over six months ago Amgen exotic insider transaction detected | ||
Stuart Tross over a year ago Amgen exotic insider transaction detected |
Amgen Management Efficiency
The company has return on total asset (ROA) of 0.0997 % which means that it generated a profit of $0.0997 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 1.2647 %, meaning that it generated $1.2647 on every $100 dollars invested by stockholders. Amgen's management efficiency ratios could be used to measure how well Amgen manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | PRESIDENT Age | ||
Andrew Iaboni | McEwen Mining | 41 | |
Brady Connor | Verizon Communications | N/A | |
Daniel Mead | Verizon Communications | 60 | |
Christopher Newkirk | Capital One Financial | 47 | |
Christopher Stewart | McEwen Mining | 47 | |
Michael Harrington | First Republic Bank | N/A | |
Anthony Skiadas | Verizon Communications | 48 | |
Hans Vestberg | Verizon Communications | 58 | |
Jason Bender | First Republic Bank | 47 | |
Anne Lloyd | Martin Marietta Materials | 53 | |
Ryan Schneider | Capital One Financial | 45 | |
Michael Wassmer | Capital One Financial | 53 | |
Roy Chestnutt | Verizon Communications | 53 | |
Olga Tsokova | First Republic Bank | 50 | |
Colin Sutherland | McEwen Mining | 42 | |
Richard Teets | Steel Dynamics | 68 | |
Matthew Ellis | Verizon Communications | 52 | |
John Mohr | Martin Marietta Materials | 58 | |
Simon Quick | McEwen Mining | 28 | |
Stephanie Bontemps | First Republic Bank | 57 | |
Dale Smith | First Republic Bank | N/A |
Management Performance
Return On Equity | 1.26 | |||
Return On Asset | 0.0997 |
Amgen Inc Leadership Team
Elected by the shareholders, the Amgen's board of directors comprises two types of representatives: Amgen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amgen. The board's role is to monitor Amgen's management team and ensure that shareholders' interests are well served. Amgen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amgen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Linda Louie, VP Officer | ||
Frank Herringer, Independent Director | ||
Nancy Grygiel, Sr Officer | ||
Francois Carbonnel, Independent Director | ||
Rebecca Henderson, Independent Director | ||
Annette Such, Chief Accounting Officer | ||
Sanders Williams, Independent Director | ||
Vance Coffman, Lead Independent Director | ||
David Reese, Executive Vice President - Research and Development | ||
Tyler Jacks, Independent Director | ||
Brian McNamee, Executive Vice President - Full Potential Initiatives | ||
Gregory Garland, Independent Director | ||
Charles Holley, Director | ||
Esteban Santos, Executive Vice President Operations | ||
Jonathan Graham, Senior Vice President General Counsel, Secretary | ||
Sean Harper, Executive Vice President - Research and Development | ||
Mike Zahigian, VP Officer | ||
Ellen Kullman, Director | ||
Frank Biondi, Independent Director | ||
Arvind Sood, IR Contact Officer | ||
David Meline, CFO and Executive VP | ||
Ronald Sugar, Independent Director | ||
Stuart Tross, Senior Vice President - Human Resources | ||
Robert Bradway, Chairman, CEO and President Chairman of Executive Committee and Member of Equity Award Committee | ||
Murdo Gordon, Executive Vice President of Global Commercial Operations | ||
Peter Griffith, Ex CFO | ||
Wanda Austin, Independent Director | ||
Robert Eckert, Independent Director | ||
Madhavan Balachandran, Executive VP of Operations | ||
Lori Johnston, Senior Vice President - Human Resources | ||
Brian Druker, Independent Director | ||
Cynthia Patton, Senior Vice President Chief Compliance Officer | ||
Greg Garland, Independent Director | ||
Robert Williams, Independent Director | ||
Judith Pelham, Independent Director | ||
David Baltimore, Independent Director | ||
Fred Hassan, Director | ||
David Piacquad, Senior Vice President - Business Development | ||
Anthony Hooper, Executive VP of Global Commercial Operations | ||
David MD, Ex RD |
Amgen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amgen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 1.26 | |||
Return On Asset | 0.0997 | |||
Profit Margin | 0.25 % | |||
Operating Margin | 0.38 % | |||
Current Valuation | 3.36 T | |||
Shares Outstanding | 533.98 M | |||
Shares Owned By Insiders | 0.20 % | |||
Shares Owned By Institutions | 80.38 % | |||
Price To Earning | 267.53 X | |||
Price To Book | 40.33 X |
Pair Trading with Amgen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.Moving together with Amgen Stock
0.66 | ROGN | Roche Holding AG | PairCorr |
Moving against Amgen Stock
0.65 | AXTELCPO | Axtel SAB de Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Amgen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen Inc to buy it.
The correlation of Amgen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Amgen Stock analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |